TXMD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	10 579.00
Average Volume	22 437.00
Market Cap	21.57M
EPS	$-0.130 ( 2023-11-13 )
Next earnings date	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.53
ATR14	$0.0120 (0.64%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-05	Walker Marlan D	Buy	70 000	Common Stock
2023-12-06	Walker Marlan D	Sell	14 500	Common Stock
2023-12-07	Walker Marlan D	Sell	4 550	Common Stock
2023-12-05	Walker Marlan D	Sell	70 000	Restricted Stock Units
2023-11-15	Rubric Capital Management Lp	Buy	877 192	Common Stock, par value $0.001 per share ("Common Stock")

INSIDER POWER
77.19
Last 94 transactions
Buy: 1 627 514 \| Sell: 264 866

TherapeuticsMD Inc Correlation

10 Most Positive Correlations
DISCB	0.805

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

TherapeuticsMD Inc Financials

Annual	2023
Revenue:	$1.30M
Gross Profit:	$380 000 (29.19 %)
EPS:	$-0.980

Q4	2023
Revenue:	$502 000
Gross Profit:	$-135 000 (-26.89 %)
EPS:	$-0.0766

Q3	2023
Revenue:	$-53 000.00
Gross Profit:	$-183 000 (345.28 %)
EPS:	$-0.320

Q2	2023
Revenue:	$437 000
Gross Profit:	$309 000 (70.71 %)
EPS:	$-0.240

Financial Reports:

No articles found.

TherapeuticsMD Inc

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.